Last reviewed · How we verify
Familial Mediterranean fever
Approved treatments
- Colcrys · Scilex Pharms
Colcrys works by inhibiting the activity of a specific enzyme called serine/threonine-protein kinase pim-1. - Anakinra · Biovitrum Ab
- Ilaris · Novartis Pharms
- Kineret · Biovitrum Ab
Kineret blocks the action of interleukin-1, a protein that promotes inflammation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Familial Mediterranean fever patent landscape — cliff calendar, originator estates, attackable patents
- Familial Mediterranean fever treatment landscape brief
- Familial Mediterranean fever treatment updates RSS
Frequently asked questions about Familial Mediterranean fever
What drugs treat Familial Mediterranean fever?
Tracked treatments include Colcrys, Anakinra, Ilaris, Kineret.
What is the treatment for Familial Mediterranean fever?
Standard treatment for Familial Mediterranean fever includes Colcrys, Anakinra, Ilaris, Kineret. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Familial Mediterranean fever patent cliff · Familial Mediterranean fever CI report
- Treatment: Colcrys · Scilex Pharms
- Treatment: Anakinra · Biovitrum Ab
- Treatment: Ilaris · Novartis Pharms
- Treatment: Kineret · Biovitrum Ab
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing